RESEARCH SUPPORT, N.I.H., INTRAMURAL
Add like
Add dislike
Add to saved papers

Acupuncture for symptom management in patients with hyper-IgE (Job's) syndrome.

OBJECTIVES: The objective of this study was to investigate the effects of acupuncture treatment for symptom management in patients with hyper-immunoglobulin E (IgE) syndrome (HIES).

DESIGN: This was a retrospective case series.

SETTING/LOCATION: The study was conducted at the The Clinical Research Center of the National Institutes of Health.

SUBJECTS: There were 8 adult patients with HIES ages 23-56 with varying symptoms in the study.

INTERVENTION: Acupuncture treatments were given from May 29, 2001 to February 17, 2009.

OUTCOME MEASURES: Acupuncture treatment efficacy was measured and evaluated using a 0-10 assessment instrument pre- and post-treatment.

RESULTS: The 8 patients with HIES suffered from a wide variety of symptoms related to the disease. Acupuncture treatments uniformly decreased the self-reported severity of symptoms.

CONCLUSIONS: This case series demonstrates that acupuncture is a clinically useful and safe therapy for symptom management in patients with HIES.

Full text links

For the best experience, use the Read mobile app

Group 7SearchHeart failure treatmentPapersTopicsCollectionsEffects of Sodium-Glucose Cotransporter 2 Inhibitors for the Treatment of Patients With Heart Failure Importance: Only 1 class of glucose-lowering agents-sodium-glucose cotransporter 2 (SGLT2) inhibitors-has been reported to decrease the risk of cardiovascular events primarily by reducingSeptember 1, 2017: JAMA CardiologyAssociations of albuminuria in patients with chronic heart failure: findings in the ALiskiren Observation of heart Failure Treatment study.CONCLUSIONS: Increased UACR is common in patients with heart failure, including non-diabetics. Urinary albumin creatininineJul, 2011: European Journal of Heart FailureRandomized Controlled TrialEffects of Liraglutide on Clinical Stability Among Patients With Advanced Heart Failure and Reduced Ejection Fraction: A Randomized Clinical Trial.Review

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app

Read by QxMD is copyright © 2021 QxMD Software Inc. All rights reserved. By using this service, you agree to our terms of use and privacy policy.

Get seemless 1-tap access through your institution/university

For the best experience, use the Read mobile app